This research article provides an in-depth analysis of the effects of lagering conditions on the performance of Dry Powder Inhalers (DPIs). The study systematically evaluates a range of physicochemical properties under different storage conditions and time periods. The research further investigates the interfacial behavior of Fluticasone Propionate (FP) samples with various substances and compares the in vitro performance of binary and tertiary DPI formulations. The findings of this study can significantly contribute to the understanding and prediction of inter particulate forces of secondary processing of APIs in DPI systems, which is crucial for optimizing DPI product performance.
Innovation & Insights
Interview with Jane Provis Evans, Head cGMP services at Nanopharm
In the ever-evolving world of pharmaceuticals, the importance of stringent quality control cannot be overstated. This interview with Jane Provis-Evans, Head of cGMP Analysis at Nanopharm, sheds light on the critical role of cGMP testing in the development and optimization of drug-device combinations, particularly for orally inhaled and nasal drug products (OINDPs). With the launch of Nanopharm’s new GMP services, the company is well-positioned to help clients bring innovative treatments to patients.
October 10, 2024
No Comments
